Nathaniel Weygant
机构: Professor, Fujian University of Traditional Chinese Medicine
每年引用次数
引用次数
引用: 2,005
H-指数: 28
I10-指数 : 34
出版物: 113
DCLK1 promotes tumour invasion and metastasis through epithelial-mesenchymal transition and the MEK/ERK pathway in esophageal squamous cell carcinoma
J. Yao , X. Fan , Y. Ge , J. Liu
Annals of Oncology 30
2019
DCLK1 as part of EMT feedback-loop promotes colorectal cancer cell proliferation, invasion, and 5-Fu resistance
Y. Ge , N. Weygant , D. Qu , C.W. Houchen
Annals of Oncology 29
2018
Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation
Nathaniel Weygant , Longbo Zhang , Longbo Zhang , Quan Cheng
Cell Proliferation 54 ( 3)
44
2021
Qingda granule exerts neuroprotective effects against ischemia/reperfusion-induced cerebral injury via lncRNA GAS5/miR-137 signaling pathway
Nathaniel Weygant , Jun Peng , Shan Lin , Ling Zhang
International Journal of Medical Sciences 18 ( 7) 1687 -1698
2021
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization.
Parthasarathy Chandrakesan , Janani Panneerselvam , Randal May , Nathaniel Weygant
Molecular Cancer Therapeutics 19 ( 7) 1539 -1549
3
2020
241 Small Molecule Inhibitors Xmd8-92 and Pv1019 Inhibit Pancreatic Tumor Xenograft Growth via a DCLK1 Dependent Mechanism
Sripathi M. Sureban , Dongfeng Qu , Parthasarathy Chandrakesan , Randal May
Gastroenterology 144 ( 5)
2013
404 Functional Significance of DCLK1 in the Regulation of Molecular Signaling Is Critical for Intestinal Epithelial Cell Functioning/Survival Following 24h Radiation Injury
Parthasarathy Chandrakesan , Randal May , Dongfeng Qu , Nathaniel Weygant
Gastroenterology 144 ( 5) S -78
2013
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.
Kenneth J Vega , Randal May , Sripathi M Sureban , Stan A Lightfoot
Journal of Gastroenterology and Hepatology 27 ( 4) 773 -780
50
2012
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers.
Yang Ge , C. Benedikt Westphalen , Wen Wee Ma , Kenneth J. Vega
Journal of Oncology 2019 4835318
1
2019
Su2004 A 15-miRNA-Surrogate Signature for Doublecortin-Like Kinase 1 Tumor Stem Cell Marker Activity Predicts Survival in Colon, Pancreatic, and Stomach Cancer
Nathaniel Weygant , Yang Ge , Dongfeng Qu , Randal May
Gastroenterology 150 ( 4)
2016
Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis.
Dongfeng Qu , Nathaniel Weygant , Randal May , Parthasarathy Chandrakesan
PLOS ONE 10 ( 8)
31
2015
Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
Parthasarathy Chandrakesan , Randal May , Dongfeng Qu , Nathaniel Weygant
Oncotarget 6 ( 31) 30876 -30886
29
2015
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
Sripathi M. Sureban , Mohammad F. Madhoun , Randal May , Dongfeng Qu
Oncotarget 6 ( 35) 37200 -37215
52
2015
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4.
Janani Panneerselvam , Priyanga Mohandoss , Ravi Patel , Hamza Gillan
Molecular Therapy - Oncolytics 18 24 -36
2
2020
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
Nathaniel Weygant , Dongfeng Qu , William L Berry , Randal May
Molecular Cancer 13 ( 1) 103 -103
101
2014
Abstract LB-48: DCLK1 targeted monoclonal antibodies demonstrate therapeutic potential against pancreatic ductal adenocarcinoma
Dongfeng Qu , Nathaniel Weygant , Randal May , Parthasarathy Chandrakesan
Cancer Research 74
2014
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism
Sripathi M Sureban , Randal May , Nathaniel Weygant , Dongfeng Qu
Cancer Letters 351 ( 1) 151 -161
64
2014
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer
Dongfeng Qu , Nathaniel Weygant , Jiannan Yao , Parthasarathy Chandrakesan
Journal of Oncology 2019 6402925
9
2019
DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
Sripathi M. Sureban , Randal May , Dongfeng Qu , Nathaniel Weygant
PLOS ONE 8 ( 9)
95
2013
Su1862 RNA Binding Protein Musashi-1 Regulates Tumorigenesis and Angiogenesis via MicroRNA-Dependent Mechanism
Sripathi M. Sureban , Randal May , Dongfeng Qu , Parthasarathy Chandrakesan
Gastroenterology 146 ( 5)
2014